Early Phase 1 Transplant Recipient Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more

Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069

Recruiting

Early Phase 1

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Actinic Keratosis (AK)+1 more

Marissa Lobl20 enrolled2 locationsNCT07286318

Recruiting

Early Phase 1

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Skin CancerKidney Transplant Recipients

Rhode Island Hospital30 enrolled1 locationNCT05702398